MedTrace Logo

Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan

NCT04779853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2021-03-03

No results posted yet for this study

Summary

Seroprevalence of pertussis among older children and adolescents in Kazakhstan: A cross sectional study.

Justification: to describe the distribution of anti-pertussis toxin (PT) antibodies (IgA and IgG) in a population aged 10-18 years old according to sociodemographic characteristics, vaccination history, and risk factors of pertussis infection.

Conditions

  • Pertussis

Interventions

DIAGNOSTIC_TEST

Blood samples for pertussis antibody testing

Blood samples will be sent to the laboratories of the National Centers of Expertise within 24-48 hours of blood collection. The samples will be transferred to the reference laboratory of SPCSEEM in Almaty, Kazakhstan. Serum samples will be stored in the reference laboratory at a temperature of -20 C.

Sponsors & Collaborators

  • Scientific and practical center of sanitary and epidemiological expertise and monitoring

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-25
Primary Completion
2021-10-17
Completion
2022-07-05

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04779853 on ClinicalTrials.gov